Default: BMC Biotechnology

ISSN:

Journal Home

Journal Guideline

BMC Biotechnology Q2 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BMC Biotechnology is a journal indexed in SJR in Biotechnology with an H index of 88. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2090 €. The scope of the journal is focused on biotechnology. It has an SJR impact factor of 0,654 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,654.

BMC Biotechnology focuses its scope in these topics and keywords: dna, rna, sedimentsautomated, serial, sitespecific, specimensdesign, technologya, tidal, tissue, treatmentsequential, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ WOS
Categories: Biotechnology (Q2)
Price

2090 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

BMC Biotechnology

0,654

SJR Impact factor

88

H Index

38

Total Docs (Last Year)

233

Total Docs (3 years)

1462

Total Refs

830

Total Cites (3 years)

233

Citable Docs (3 years)

3.54

Cites/Doc (2 years)

38.47

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


dna, rna, sedimentsautomated, serial, sitespecific, specimensdesign, technologya, tidal, tissue, treatmentsequential, yeast, receptor, flat, cancer, agonist, edbtargeting, alkaline, antibody, biobanked, cassettes, counterselectable, development, adiponectin, extraction, fission, inteinfusion, metagenome, modification, peptidebased, phosphatase, biotechnology

FAQS